Nuritas Targets Food and Beverage Formulations with Precision Peptides

For dietary supplement manufacturers, the traditional boundaries of delivery systems are shifting. Consumers increasingly seek functional benefits beyond conventional capsules and tablets, driving demand in the functional food and beverage market. Addressing this evolution, biotechnology firm Nuritas has announced its participation in the upcoming IFT FIRST 2026 annual meeting and exposition in Chicago, Illinois.¹ The company plans to showcase its portfolio of plant-based peptide hydrolysates, highlighting how clinically validated ingredients can be successfully integrated into standard food systems without compromising stability or bioavailability. The company will be at booth #869 to meet with brands, food and beverage manufacturers, and formulation teams.

How Stable Are Bioactive Peptides in Food Processing and Formulations?

Transitioning bioactive peptides from standardized supplements to active food matrices requires ingredients capable of surviving real-world manufacturing environments. Unlike compounds vulnerable to degradation, these peptide hydrolysates are supplied as functional powders engineered to withstand industrial food processing variables.

Application testing has demonstrated that the ingredients maintain heat stability during demanding retort and ultra-high temperature (UHT) processing across various pH levels. This structural stability allows for inclusion in shelf-stable beverages and acidic food systems. At the upcoming exhibition, the company will demonstrate ingredient integration across four specific categories:

• Frozen Yogurt: Featuring PeptiStrong in a format designed to meet consumer interest in functional dairy and active-aging products
• RTD & RTM Beverages: Highlighting heat-stable formulations validated under commercial retort and UHT conditions
• Functional Snacks: Moving beyond conventional protein bars to introduce savory concepts like peptide-infused crisps and puffed snacks
• Bakery: Incorporating functional peptides into baked bars and breakfast products to seamlessly align with daily purchasing habits

“Functional benefits do not have to be confined to capsules or powder blends. At IFT, we are showing how our peptide hydrolysates can move into yogurt, beverages, crisps, and bakery, all while maintaining bioavailability throughout processing, explained Nora Khaldi, PhD, CEO and Founder of Nuritas.

How Does Nuritas Utilize AI Discovery and Clinical Validation for its Ingredients?

At the core of the company’s ingredient development is its proprietary, artificial intelligence-powered platform known as "Magnifier". The platform utilizes computational biology to identify specific bioactive peptide sequences within natural food sources.² By predicting and isolating these targets, the company aims to accelerate ingredient discovery while ensuring a foundation in whole-food–derived bioactivity.

The company's commercial portfolio includes PeptiStrong, a fava bean–derived peptide complex, which targets muscle health, longevity, and recovery, as well as PeptiSleep, which targets sleep quality and next-day wellness. These ingredients are backed by human clinical data. For instance, a randomized, double-blind, placebo-controlled trial published in Nutrients demonstrated that PeptiStrong supplementation improved strength recovery and reduced muscle fatigue in healthy men. Furthermore, research published in The Journal of Nutrition indicated that the ingredient significantly improved muscle protein synthesis rates during recovery in a cohort of young health men, outperforming milk protein in specific parameters. Preclinical evaluation also suggests mechanistic support, including the downregulation of genes related to muscle atrophy and the upregulation of protein-synthesis pathways.

What Is the Global Regulatory Status of Nuritas Functional Ingredients?

For brands looking to diversify into functional foods, regulatory compliance is a significant part of market entry. The company reports that its portfolio has achieved FDA Generally Recognized as Safe (GRAS) status in the United States, alongside Non-Novel Food designations in both Canada and the European Union. Currently, these ingredients are market-ready across more than 20 countries and have been utilized in over 100 commercial product launches globally.

References

1. Nuritas. Nuritas Takes Peptide Science to the Food Aisle at IFT FIRST 2026. June 2026. Accessed June 18, 2026. Press release provided via email.
2. McEvoy E. Nuritas highlights muscle health potential of plant-derived peptides at Expo West. February 12, 2026. Accessed June 18, 2026. https://www.nutritionaloutlook.com/view/nuritas-highlights-muscle-health-potential-of-plant-derived-peptides-at-expo-west